Dr. Brandi Langdon, FNP
What this data tells you about Dr. Langdon
Dr. Brandi Langdon is a nurse practitioner - family in Texarkana, TX, with 20 years in practice. Based on federal Medicare data, Dr. Langdon performed 4,581 Medicare services across 1,981 unique beneficiaries.
Between the years covered by Open Payments, Dr. Langdon received a total of $3,041 from 34 pharmaceutical and/or device companies across 191 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Langdon is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $25 |
| Office visit, established patient (20-29 min) | 313 | $53 | $175 |
| Blood draw (venipuncture) | 278 | $8 | $20 |
| Complete blood count (CBC) with differential | 244 | $8 | $48 |
| Comprehensive metabolic blood panel | 240 | $10 | $105 |
| Urinalysis with microscopic exam | 237 | $3 | $28 |
| Office visit, established patient (30-39 min) | 177 | $70 | $244 |
| Lipid panel (cholesterol and triglycerides) | 165 | $13 | $90 |
| Urine microalbumin test (kidney screening) | 130 | $6 | $58 |
| Thyroid stimulating hormone (TSH) test | 124 | $16 | $86 |
| Vitamin D level test | 120 | $29 | $250 |
| Urine culture, bacterial identification | 110 | $8 | $42 |
| Free thyroxine (T4) test | 84 | $9 | $52 |
| Drug injection, under skin or into muscle | 82 | $9 | $42 |
| Annual wellness visit, follow-up | 73 | $107 | $220 |
| Hemoglobin A1c test (diabetes monitoring) | 67 | $10 | $61 |
| Flu vaccine administration | 57 | $30 | $35 |
| Flu vaccine, high-dose | 56 | $72 | $75 |
| Injection, ketorolac tromethamine, per 15 mg | 48 | $0 | $17 |
| Bacterial culture, aerobic | 46 | $8 | $40 |
| Antibiotic sensitivity test | 46 | $8 | $58 |
| Removal of impacted ear wax | 43 | $28 | $113 |
| Vitamin B-12 level test | 43 | $15 | $70 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 28 | $45 | $58 |
| Basic metabolic blood panel | 26 | $8 | $88 |
| Iron level test | 19 | $6 | $39 |
| Transferrin (iron binding protein) level | 19 | $12 | $50 |
| Prostate cancer screening; prostate specific antigen test (psa) | 19 | $19 | $79 |
| Transitional care management services for problem of at least moderate complexity | 15 | $126 | $280 |
| Ferritin level test (iron stores) | 14 | $13 | $52 |
| Pneumonia vaccine administration | 14 | $30 | $45 |
| Administration of vaccine | 13 | $11 | $48 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $35 | $155 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for nurse practitioner - family in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Langdon is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 9%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Langdon experienced with denosumab injection (prolia/xgeva)?
Does Dr. Langdon receive payments from pharmaceutical companies?
How do Dr. Langdon's costs compare to other nurse practitioner - familys in Texarkana?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology